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ABStrAct
Sub-Saharan Africa has a documented significant burden of heroin and cocaine injection, 
and HIV transmission. But the region is behind in the implementation and scaling up of 
harm reduction measures such as syringe exchange programmes and opiate substitution 
therapy, due to political preference for the control of drug supply through legal 
prohibition. Though the policy environment is changing and small-scale programmes 
are emerging in some countries, large-scale programmes needed to stem HIV epidemic 
among people who inject drugs are bedevilled by social, cultural and political barriers. 
For example, current models of harm reduction are problematic in sub-Saharan Africa 
because they elevate the individual and his or her rights above the society and its 
needs, and they focus on behavioural changes and do not take into account the social 
factors that predispose people to drug harms. There is need to align harm reduction 
programmes with the realities of local contexts in order to guarantee local acceptance 
as well as increase the potentials for sustainability. 
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introDuction
There is significant disillusionment in 
many parts of the world with the domi-
nant, prohibitionist approach to illicit 
drugs control. The approach, which rests 
on the three international conventions, 
namely the 1961 Single Convention on 
Narcotic Drugs, the 1971 Convention on 
Psychotropic Substances, and the 1988 
Convention against Illegal Traffic in Nar-
cotic Drugs and Psychotropic Substances, 
attempt to control the supply and use of 
illicit drugs by means of legal prohibition. 
After roughly six decades of attempting 
to control the use of drugs by suppress-
ing production and distribution, it is now 
widely acknowledged that the approach 
is of limited effectiveness. Production and 
trafficking have been suppressed in some 
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places, but they have ballooned else-
where. Demand for cocaine, heroin and 
new synthetic drugs are on the increase 
globally (UNODC, 2012). 
Across the world, counter-narcotic 
operations have engendered political in-
stability, violence, corruption, mass in-
carceration, and violations of the human 
rights of people who use drugs (PWUDs), 
including the right to health (Pollack & Re-
uter, 2014; WACD, 2014), which has been 
influential in undermining support for the 
global drug control regime, and strength-
ening the momentum for policy shift to-
wards public health and harm reduction. 
A vast body of evidence suggests that 
harm reduction measures are effective in 
preventing HIV infection among people 
who use illicit drugs; such that these pro-
grams are considered an important factor 
in the prevention of HIV among people 
who inject drugs (PWIDs) (see the review 
by Csete et. al., 2016). 
Consider, for example, syringe ex-
change and opioid substitution therapy. 
The former has been proven to be effec-
tive in reducing risk behaviour and the 
incidence of HIV and Hepatitis C (Des 
Jarlais et. al., 1996; Hagan et. al., 1995). 
It does not lead to increase in drug use, 
but is associated with substantial reduc-
tion in healthcare expenditures (Fisher 
et. al., 2003; Normand et. al., 1995). An 
international study revealed that cities 
with syringe exchange programs have 
5.8% decline in HIV prevalence per year, 
while HIV prevalence increased by 5.9% 
in cities without such programs (Hurley 
et. al., 1997). Opioid substitution ther-
apy (such as methadone) is associated 
with reduction in, and elimination of, 
illicit opiate use, reduction in risk be-
haviour, reduction in the transmission of 
HIV and viral Hepatitis, and in mortality 
rates (MacAurthur et. al., 2014; Turner 
et. al., 2011). 
Despite this evidence of effectiveness, 
harm reduction measures remain con-
troversial and highly contested in many 
places, including Sri Lanka, Turkey, North 
Africa, Eastern Europe and Russia. They 
are unpopular among African countries, 
renowned for political preference for the 
prohibitionist approach to illicit drugs, 
which is due in part to political pressure 
from the United States. Although the pol-
icy environment is changing, and small-
scale programs have emerged in some 
countries, large-scale implementation of 
harm reduction measures, which is need-
ed to arrest the epidemic of HIV and viral 
Hepatitis among people who inject drugs 
(PWIDs), is faced with many obstacles in-
cluding government opposition and/or 
indifference, stigma and discrimination of 
PWIDs, public discomfort, and socio-cul-
tural and religious barriers (Klein, 2011; 
Kelly et al., 2006; McCurdy et al., 2007). 
This paper examines the socio-cultural 
context of harm reduction in Africa with a 
view to charting the way forward.
Epidemiology of injection drug use 
Injection drug use (IDU) is a growing 
problem in Sub-Saharan Africa (SSA). SSA 
countries such as Kenya, Tanzania, Cote 
d’Ivoire, Mauritius, Morocco, Nigeria, 
Egypt, Mozambique, South Africa, Ghana, 
and Congo have a documented growing 
burden of injection drug use (Harm Re-
duction International, 2015). There are 
about 1,778,500 people who inject drugs 
(PWIDs) in the region, and about 221, 
000 of these people may be living with 
HIV (Mathers et. al., 2008). Most PWIDs 
in SSA are male, ranging from 66% in 
northern Nigeria to 93% in Nairobi, Kenya 
(DesJarlais, Perlis, Stimson & Poznyak, 
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2006; Aceijas et. al., 2006). There is a high 
prevalence of IDU among sex workers, 
ranging up to 74% in Mauritius, where a 
quarter of PWIDs are sex workers (Reid, 
2009). HIV prevalence among PWIDs in 
SSA ranges from 22.9% to 50% in Kenya, 
19.4% in South Africa, 8.9% in Nigeria to 
less than 1% in Zambia (Mathers et. al., 
2008). There is a significant problem of 
drug injecting without sterile injection 
equipment, and high risk practices such 
as the sharing of blood with other users 
who cannot afford the drug (a practise 
known as ‘flash blood’) (Atkinson et al., 
2011; McCurdy et al., 2007).
The most common drug injected in 
SSA is heroin, followed by cocaine and 
speedball, a combination of heroin and 
cocaine (Adelekan & Lawal, 2006). Heroin 
and cocaine were introduced to Africa in 
the 1980s through international traffick-
ing in psychoactive drugs to European 
and North American drug markets from 
Southeast Asia in the case of heroin and 
South America in the case of cocaine 
(Akyeampong, 2005; Ellis, 2009). West 
African countries, especially Nigeria and 
Ghana, served as the major staging posts 
in the trafficking of these drugs, trigger-
ing growth in the domestic availability 
and consumption of the drugs. In 2006, 
an estimated 0.2% of adults in Africa were 
using heroin, approximating the global 
average (Dewing, Pluddemann, Myers & 
Parry, 2006). 
Patterns of heroin use ranges from 
intermittent use among most Nigerian 
PWIDs to regular binging in Dar es Sa-
laam, Tanzania (Adelekan & Lawal, 2006; 
Ross et. al., 2008). Among young heroin 
users, the pattern varies from non-in-
jecting in coastal Kenya to widespread 
injecting in open-air youth hangouts and 
private settings in Tanzania (Beckerleg, 
2005; Dewing, Pluddemann, Myers & 
Parry, 2006). IDU is common and particu-
larly dangerous among street children. A 
study conducted among a small sample of 
street children in the Great Lakes region 
show that 43.5% reported sharing syring-
es and other drug injecting instruments 
(Leshabari & Kaaya, 2005). The age of on-
set of IDU ranges from 20 in South Africa 
to 25 in Kenya and Tanzania (DesJarlais, 
Perlis, Stimson & Poznyak, 2006; Ross et. 
al., 2008). In Nigeria, an estimated 2.4% 
of students of tertiary institutions had 
ever injected heroin, and student heroin 
use dates back to the 1980s (Obot, Karuri 
& Ibanga, 2003). 
PWIDs in SSA live in precarious con-
ditions characterized by homelessness 
and destitution. The majority of PWIDs 
hold temporary jobs, while others rely on 
begging and crime to support their drug 
use habits (DesJarlais, Perlis, Stimson & 
Poznyak, 2006; Dewing, Pluddemann, 
Myers & Parry, 2006). Knowledge of the 
risk of HIV transmission through sharing 
of needles is limited among the growing 
population of PWIDs in SSA, and many 
AIDS prevention programs in the region 
have discountenanced injection risks in 
their public awareness communications, 
perceiving IDU to be uncommon. A large 
proportion of PWIDs regularly share sy-
ringes, and in Nigeria only 25% of PWIDs 
report knowing that sharing of syringes 
carries the risk of HIV transmission (Reid, 
2009).
Harm reduction programmes
Drug use is criminalized in most SSA 
countries, and drug users are the tar-
get of spirited law enforcement opera-
tions. Government policies on psychoac-
tive drugs reflect a political preference 
for controlling drug supply, with limited 
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resources devoted to demand reduc-
tion (Reid, 2009). National and regional 
drug policies, influenced by the US and 
the international conventions which are 
contradictory, often limit resources for 
harm reduction on the grounds that they 
condone drug use (Parry & Pluddemann, 
2004). 
Sub-Sahara Africa is behind in the glob-
al efforts to implement and scale up harm 
reduction measures. Only a few countries 
in the region have implemented harm re-
duction programmes. For example, Nee-
dle and syringe exchange programmes 
(NSPs) exists only in Mauritius, Tanzania 
and South Africa, while Opioid Substitu-
tion Therapy (OST) are available only in 
Tanzania, South Africa, Kenya, Mauritius, 
and Senegal (HRI, 2012). Mauritius has 
the greatest coverage of NST in the region 
with 83.8% of people who inject drugs 
using sterile injecting equipment in 2013 
(Government of Mauritius, cited in Reid, 
2009). The 2006 HIV & AIDS Act of Mauri-
tius established the first needle exchange 
and methadone maintenance program in 
Africa in reaction to explosive HIV trans-
mission among PWIDs in an otherwise 
low-prevalence population (Kilonzo & 
Simmons, 2005). 
Most of these programmes are limited 
in scale and are far below estimates re-
quired to reverse the HIV epidemic among 
PWIDs in the region (Harm Reduction In-
ternational, 2015). The services are most-
ly provided by CSOs, and there is limited 
government support for and involvement 
in the provision of harm reduction servic-
es. This has contributed in no small way to 
the exacerbation of unsafe injection prac-
tices and HIV transmission among PWIDs 
(Reid, 2009; Wolf & Csete, 2010). There 
has been intense advocacy for the adop-
tion of harm reduction in SSA (Abdool, 
2016; Tammi, 2004). The policy environ-
ment is slowly changing, with the spread 
of HIV and HCV among PWIDs stimulating 
domestic support for harm reduction pro-
grammes such as NSP and OST. 
In 2007 the Sub-Saharan Africa Harm 
Reduction Network (SAHRN) was formed, 
and NGOs, researchers and UN represent-
atives from eleven African countries met 
to deliberate on drug policies (IHRA, cited 
in Reid, 2009). The tempo of advocacy 
for harm reduction has increased and the 
policy environment is gradually changing. 
But barriers still exists, especially those 
related to moral panic and other socio-
cultural factors which make current mod-
els of harm reduction programs prob-
lematic in SSA. We examine two of these 
‘conundrums’ in the succeeding sections. 
‘rights talk’ and the individual/society 
conundrum 
The provision of harm reduction ser-
vices is an aspect of a public health re-
sponse to drug addiction, understood as 
a chronic, relapsing brain disease. This ap-
proach is premised on a medical model of 
human behaviour where drug addiction 
is ‘the result of disturbance in the proper 
functioning of neurological communica-
tion’ (Perez & Espositio, 2010: 94). Ac-
cording to this perspective, although the 
drug user is regarded as an active agent 
in initial drug experimentation and use, 
addiction is thought to develop from fac-
tors that are largely independent of the 
actor’s purposeful action (Ibid). Accord-
ing to Tatarsky, ‘[t]he disease is believed 
to have a life of its own, separable from 
the complex of issues that influence the 
life of the user. The disease is deemed a 
permanent, lifelong condition…’ (2002: 
19). For this reason, medical intervention 
to minimize the harms associated with 
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this ‘permanent, lifelong condition’ is 
not only a rational response, but also the 
‘right’ of the individual who is addicted to 
drugs. Failure to provide these services is 
regarded as a denial of the health right of 
the individual. 
The concept of human rights underly-
ing harm reduction is rooted in liberal po-
litical theory. It reflects an atomistic and 
individualistic cultural ethos, where the 
rights of the individual are in perpetual 
conflict with the needs of the society. It 
“presupposes a society of people who 
are conscious of their separateness and 
their particular interests and are anxious 
to realize them” (Ake, 1987: 83). In this 
context, human rights are a “claim which 
the individual may make against the oth-
er members of society, and simultane-
ously an obligation on the part of society 
to uphold this claim” (Ibid). This concept 
emerged from the historical context of the 
western world as a measure to check the 
invasive and abusive modern state, lead-
ing to the “sacralisation of the individual 
and the supremacy of the jurisprudence 
of individual rights” (Mutua, 2013:71).
Claims about their universality not-
withstanding, human rights are context-
specific. Indeed, as Langlois (2009: 20) 
points out, “the reasoning from which 
the universality derives is a very particu-
lar way of thinking about what it is to be 
human, which might not legitimately ap-
ply to all human persons”. Human rights 
concepts reflect the social context from 
which they emerged; they do not align 
with African cultures values. They are an 
essentially western concept, one at odds 
with the cultural and philosophical tradi-
tions of African peoples (Goodhart, 2009: 
4). As Waters (1996: 593) puts it, “human 
rights is an institution that is specific to 
cultural and historical context just like any 
other and… its very universality is itself a 
human creation”. 
Liberal human rights ascribe abstract 
rights to individuals (Ake, 1987), which 
are hardly realizable in non-western con-
texts. In African societies, only those who 
possess the power to actualize these 
rights enjoy them. Therefore, PWUDs do 
not enjoy liberal human rights because 
they do not have the means to realize 
them. Neither can the state be relied on 
to actualize human rights. It is common 
knowledge that the state is a major cul-
prit in the violation of human rights in Af-
rica, especially the rights of marginalized 
groups such as drug users. The abuse of 
drug users’ rights is part of an abysmal re-
cord of human rights protection in most 
developing countries (Takahashi, 2009). 
For the majority of drug users, human 
rights are vague, elusive and irrelevant 
because they are not realizable. For ex-
ample, the right to health presupposes 
the availability of healthcare services. But 
in most countries of SSA, healthcare is ei-
ther unavailable or unevenly distributed. 
PWUDs suffers double disadvantage be-
cause of stigma and discrimination. Health 
right is abstract and elusive for PWUDs in 
SSA because prevailing conditions render 
them implausible. This confirms Short’s 
(2009: 93) argument that “‘rights’ are not 
simply givens, or necessarily beneficial to 
right holders; rather they are the prod-
ucts of social and political manipulation”. 
Furthermore, African societies exhibit 
what has been described as a ‘collective 
value system’ (Herskovits, cited in Good-
hart, 2009), which place the group above 
the individual (Menkiti, 1990). The indi-
vidual receives identity and status from 
his/her membership in the group. The 
individual is not granted any right that 
undermines the needs of the society. 
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African traditional cultures place premi-
um on harmony and cooperation above 
competition and conflict. They emphasize 
the individual obligation to society above 
the rights he/she can claim against soci-
ety (Ake, 1987). Individual entitlements 
are valid to the extent that they do not 
infringe on the rights of the group, and 
they are curtailed when they threaten the 
latter. The collective value system of Afri-
can societies may be one of the reasons 
why African states prefer approaches to 
drug problems that address the concerns 
of the society to those that prioritize indi-
vidual rights.
Moreover, in traditional African societ-
ies individuals are endowed with rights 
as well as obligations. The individual has 
rights by virtue of his or her membership 
in the group. The right is a claim to be ex-
ercised under specific conditions, and the 
society is expected to provide the condi-
tions necessary for the realization of such 
rights. On the other hand, the obligations 
of the individual to the society are the 
duties he or she is expected to perform 
to enable the realization of the rights of 
other members of the society. As Cobbah 
(in Mutua, 2013: 83) has contended, “the 
right of one kinship member is the duty of 
the other and the duty of the other kin-
ship member is the right of another”. The 
rights and obligations of group members 
constitute the basis of kinship system in 
African societies. 
Liberal human rights are problematic 
in the African context because they di-
vorce the rights of the individual from 
his or her obligation and responsibility 
to the society, including that of protect-
ing the honour, safety and well-being of 
the family and community. This is part of 
the reason why harm reduction measures 
are unpopular in Africa. They perceived 
as encouraging a behaviour that violates 
group values. They are at odds with Af-
rican cultural values, which elevate the 
group above the individual (Mutua, 2013: 
71). Harm reduction programs must re-
flect the collective value system of African 
societies in order to generate local accep-
tance. 
‘Social suffering’ and the behaviour/
structure conundrum 
Harm reduction is conventionally re-
garded as a set of interventions aimed at 
reducing harms associated with the use of 
illicit drugs (Obot, 2007). It assesses actual 
harms resulting from the use of particular 
substances and proposes pragmatic and 
morally-neutral measures for minimiz-
ing them. Harm reduction is popular be-
cause it fosters improved understanding 
of drug use behaviour and supports the 
adoption of specific strategies to address 
them. But it also has an ideological com-
ponent, which is the object of enormous 
criticisms. 
It has been argued that harm reduc-
tion functions as a form of ‘governmen-
tality’ (Foucault, 1979) or a way of ex-
ercising state power in late modernity 
(Gordon, 1991; Dean, 1999; Beck, 2000). 
It reflects the neoliberal shift from di-
rect state intervention to the devolution 
of power throughout social institutions 
(Roe, 2005). In this context, government 
operates through non-governmental bod-
ies such that all citizens play a role in the 
governance of self and others (Ibid, 246). 
Harm reduction therefore features as 
an approach to addressing drug-related 
harms that relies on self-regulation. Drug-
related harms are minimized by means 
of individual behavioural adjustments as 




Harm reduction has also been labelled 
‘surveillance medicine’ (Miller, 2001; 
Petersen & Lupton, 1996), where pa-
tients’ monitor their life-styles for indica-
tors of deviation from responsible citizen-
ship, and conformity is enforced through 
medicalization (Tammi, 2004). This has 
the unintended consequence of divert-
ing attention away from the culpability 
of the state in the creation of a ‘risk envi-
ronment’ for drug-related harms. But reli-
ance on behavioural adjustments, includ-
ing the use of sterile injecting equipment 
and substitute drugs, while neglecting the 
risk environment for drug-related harms 
is disingenuous. 
Current models of harm reduction, 
with its focus on behaviour, often over-
looks the fact that human behaviour 
takes place within specific social con-
texts, and that behavioural changes 
without corresponding changes in the 
social context will produce no lasting 
results. The individual-centered, behav-
iourist paradigm of harm reduction does 
not adequately address the fact that the 
choices and actions of drug users are in-
fluenced by complex social factors. As 
Buchanan et. al. (2002: 40) pointed out, 
drug use behaviours are “largely symp-
tom of deeper social structural inequali-
ties and… efforts to eliminate illegal nar-
cotics use are, and will continue to be, 
futile until we as a society address these 
fundamental antecedent political-eco-
nomic problems”. 
From the perspective of political econ-
omy, it is socio-economic conditions that 
render particular sectors of the popula-
tion vulnerable to drug use and harms. 
This includes socially marginalized groups 
such as youths, slum dwellers and com-
mercial sex workers. Drug use and harms 
is therefore a “feature of the political 
economy of social suffering” (Rhodes, 
2009: 196). It is, in Singer’s words, an ‘op-
pression illness’ (2004: 17), which is the 
“product of the impact of suffering from 
‘social mistreatment’; a type of stress 
disorder, where the source of the stress 
is ‘being the object of widespread and 
enduring discrimination, degradation, 
structural violence and abusive derision’; 
whether overt or hidden” (Ibid: 17). It is 
“a process through which an oppressive 
environment is incorporated into the ev-
eryday practices of those subjected to 
multiple subordinations” (Friedman et. 
al., 1998).
Sub-Sahara Africa is faced with numer-
ous political economic problems, includ-
ing poverty, unemployment, political in-
stability and social conflicts. The growth 
of human population is not paralleled by 
economic growth and equitable distribu-
tion of income. The state in Africa oper-
ates like a criminal syndicate plundering 
public resources for private enrichment 
(Bayart, Ellis & Hibou, 1999), and relies 
on violence to curb threats to its exis-
tence. The populace live in precarious 
conditions characterized by scarcity of 
basic social services such as sanitation, 
clean water, healthcare and housing. 
The bulk of the population earn a living 
by manoeuvring a poorly regulated and 
squalid informal sector, where the lines 
between the licit and illicit are blurred 
(Klein, 2009). 
Social suffering is a major explanation 
for illicit drugs use and harms in SSA. It 
has been hinted that psychoactive sub-
stances may be used as self-medication 
(Ibid), by individuals to treat the psycho-
logical symptoms from which they suf-
fer (West, 2006). Living conditions in SSA 
are so traumatizing that “any substance 
helping to alleviate or control aggressive 
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impulses could be argued to be playing 
an important social function” (Ibid, 385). 
Singer suggests that drug use is a form of 
‘self-medication’ for oppression illness 
(Singer, 2004: 17). Elsewhere he argues 
that oppression illness ‘pressures suf-
ferers to seek relief’ through drug use, 
which is an ‘action-oriented culture’ em-
phasising ‘gratification’, ‘pain intolerance’, 
‘chemical intervention’ and a ‘solution’ 
(Singer, 2001: 205). 
Harm reduction programs incorporate 
this risk environment for drug harms. Ac-
cording to Ezard (2001), harm reduction 
must include not just reduction of harm 
and/or risk, but also the reduction of vul-
nerability and the ‘complex of underlying 
factors’ at the individual, community and 
societal level that ‘constrain choices and 
limit agency’ and thereby predispose one 
to the risk of drug-related harm. As noted 
by Elliot et. al. (2005: 119), this highlights 
the need for “positive action by states to 
address economic and social rights as part 
of the response to drug use in order to re-
duce vulnerability to, and risk of, harm”. 
Any approach that divorces drug harms 
from the social context from which they 
arise will fail to improve the condition of 
PWUDs in a realistic way.
concluSion 
Although harm reduction programs 
present potentials for minimizing drug-
related harms such as the transmission 
of HIV and viral hepatitis among PWIDs, 
current models are unpopular in SSA 
because they elevate individual rights 
above groups needs and neglect the risk 
environment for drug harms. They have 
to be adapted to the context through a 
contingent and variable construction of 
rights claims that reflects the values of 
the societies, including values of social 
justice and collective good. Furthermore, 
harm reduction programs should be 
implemented as part of a broad-based 
response to drug use and related harms 
which incorporates the risk environment 
for drug harms in SSA. The good news 
is that the concept of harm reduction is 
adaptable to local situations to the effect 
that it is formulated not as “broad ‘top-
down’ policies, but rather as specific, 
localized programmes” (Reuter & Mac-
Coun, 1995). 
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